Published on

March 14, 2026

Last updated on

April 16, 2026

Medical Device Registration in Singapore: A Practical Guide for Foreign Manufacturers

Medical Device Registration in Singapore: A Practical Guide for Foreign Manufacturers

Medical device registration in Singapore is overseen by the Health Sciences Authority (HSA) under the Health Products Act and its subsidiary legislation.

If you are a foreign manufacturer planning to enter this market, the process is clear, but success depends on understanding the steps, meeting the requirements, and working with the right local partner.

Continue below for the full guide or contact Cisema for support with medical device registration in Singapore.

Step 1: Classify the Device and Select the HSA Evaluation Pathway

The first stage of medical device registration in Singapore is identifying the correct device classification. Singapore applies a risk-based classification system that determines the level of regulatory review required before a device can be marketed.

Singapore Medical Device Classification System (Class A, B, C, and D)

Medical devices are categorized into four risk classes. These include:

  • Class A ( Low Risk) – Examples: examination gloves, hospital beds
  • Class B (Low-to-Moderate Risk) – Examples: contact lenses, dental filling materials, medical software
  • Class C (Moderate-to-High Risk) – Examples: ventilators, orthopedic implants
  • Class D (High Risk) – Examples: heart valves, implantable defibrillators

How Device Classification Affects Medical Device Registration Requirements in Singapore

Device classification determines whether registration is required before commercialization.

  • Class A (non-sterile): These devices are generally exempt from product registration. However, a dealer’s license is still required for importation or supply.
  • Class B, Class C, and Class D: These devices must undergo medical device registration with the HSA before they can be marketed in Singapore.

To streamline regulatory review, Singapore also applies reliance pathways, allowing HSA to leverage approvals issued by major international regulatory authorities.

Recognized Reference Agencies for Medical Device Registration in Singapore

Recognized agencies include:

  • Therapeutic Goods Administration (TGA) – Australia
  • Health Canada – Canada
  • European Union – CE Mark under MDR (EU 2017/745) or IVDR (EU 2017/746)
  • Ministry of Health, Labour and Welfare (MHLW) / PMDA – Japan
  • U.S. Food and Drug Administration (FDA) – United States

HSA Evaluation Routes for Medical Device Registration in Singapore

Based on existing regulatory approvals, devices may follow different evaluation routes:

  • Full Evaluation: Comprehensive review of the complete technical dossier.
  • Abridged Evaluation: Available when the device has prior approval from an HSA reference agency.
  • Immediate or Expedited Routes: Applicable when the device has approvals from two or more recognized authorities.

These reliance pathways can significantly shorten the medical device registration timeline in Singapore.

Once the classification and evaluation pathway are confirmed, the manufacturer must appoint a local entity to act as its legal representative in Singapore.

Step 2: Appoint a Local Authorized Representative in Singapore

The first step - and arguably the most important - is to appoint a Singaporean Authorized Representative (AR). A foreign manufacturer cannot register devices directly with the HSA; the AR is the legal entity that will hold the device registration and act as the official liaison.

Why The Authorized Representative Is Essential

The AR plays a central role in the medical device registration process in Singapore. Key responsibilities include:

  • Submitting the registration application to the HSA
  • Managing communication with the regulatory authority
  • Maintaining regulatory documentation and technical records
  • Supporting post-market surveillance activities

Without appointing an AR, manufacturers cannot initiate the HSA medical device registration process.

Benefits of Using an Independent Authorized Representative in Singapore

Many foreign manufacturers choose to work with an independent Authorized Representative, like Cisema, rather than one affiliated with a distributor. This structure offers several strategic advantages:

  • Manufacturers retain ownership of their device registrations
  • Flexibility to appoint or change distributors without re-registration
  • Regulatory data and technical documentation remain under manufacturer control
  • Continuity of market access even if your commercial arrangements change

For companies planning long-term growth in Singapore, this structure provides greater control over regulatory assets and commercial strategy.

With the legal representative in place, manufacturers can proceed with preparing the regulatory submission dossier.

Step 4: Prepare the ASEAN CSDT Dossier

After appointing the Authorized Representative, the next stage is preparing the technical documentation required for medical device registration in Singapore. HSA expects the submission dossier to follow the ASEAN Common Submission Dossier Template (CSDT), supported by Singapore-specific administrative and labeling requirements.

A well-prepared dossier can make a major difference at this stage. Incomplete or poorly organized submissions often lead to delays, clarification requests, or longer review timelines. By contrast, a complete submission aligned with the correct pathway gives HSA a clear basis for review.

Step 5: Submit the Application Through MEDICS

Medical device registration applications are submitted electronically through MEDICS, the HSA’s online regulatory submission portal.

The Authorized Representative uploads the completed CSDT dossier and supporting documents to MEDICS and submits the application for review.

After submission, the process moves from preparation to regulatory evaluation.

What Happens After Submission to HSA

Once HSA receives the application, the authority begins its technical review according to the selected evaluation route.

The process typically follows these stages:

  • HSA Review – evaluation depends on pathway (full / abridged / expedited)
  • Approval & Listing – device is published in the Singapore Medical Device Register (SMDR).
  • Import & Supply – dealers must hold valid Importer’s or Wholesaler’s licenses.

At this stage, manufacturers should also evaluate the financial and timing considerations associated with the registration process.

Government Fees and Review Timelines for Medical Device Registration in Singapore

The cost and timeline for medical device registration in Singapore depend primarily on the device classification and the selected evaluation route.

HSA charges government fees per application, with different fee levels applied to Class B, Class C, and Class D registrations. Review timelines also vary depending on whether the device undergoes full evaluation or qualifies for abridged or expedited review pathways.

Details of registration fees and official turnaround times are outlined below:

Medical Devices Registration Applications Fees (SGD) TAT (in working days)
Application fees for any Class B, C or D device registration $560 NA
Class B evaluation routes
Immediate route $1,000 Immediate upon submission
Abridged route $2,010 100
Full route $3,900 160
Full route (Priority Review Scheme Route 1) $4,420 104
Full route (Priority Review Scheme Route 2) $5,660 104
Class C evaluation routes
Immediate route $3,340 Immediate upon submission
Expedited route $3,340 120
Abridged route $3,900 160
Full route $6,250 220
Full route (Priority Review Scheme Route 1) $7,000 143
Full route (Priority Review Scheme Route 2) $9,000 143
Class D evaluation routes
Expedited route $5,930 180
Abridged route $6,250 220
Full route $12,000 310
Full route (Priority Review Scheme Route 1) $13,600 202
Full route (Priority Review Scheme Route 2) $17,500 202
Class D with registrable drug evaluation routes
Abridged route $10,600 220
Full route $75,600 310

Full details are available on the HSA website.

Manufacturers can often reduce both costs and administrative complexity through strategic product grouping, such as registering devices as a:

  • Device family
  • Device system

Grouping related products within a single application can reduce the number of submissions required and lower overall regulatory costs.

Having recognized agency approvals and a complete, well-organised dossier can help you stay on the shorter end of these timelines.

Final Thoughts: Entering the Singapore Medical Device Market

Singapore offers one of the most transparent and internationally harmonized regulatory frameworks for medical devices in Asia. With a clearly defined classification system, reliance pathways based on global regulatory approvals, and a structured digital submission process, medical device registration in Singapore can be completed efficiently when properly managed.

For devices eligible for reliance routes and supported by a well-prepared ASEAN CSDT dossier, approval timelines can be as short as 4 months.

Foreign manufacturers who plan their regulatory strategy carefully — from appointing the right Authorized Representative to optimizing submission pathways — can achieve both efficient market entry and long-term regulatory stability.

If you are a medical device manufacturer with questions about how long it takes or how much it costs to register your product for the Singapore market, contact Cisema today.

Connect With Cisema

With more than 20 years of experience and a team of over 100 specialists, Cisema helps global companies achieve compliance across Asia Pacific with confidence and accelerate market entry.

Contact Our Consultants & Discover How We Can Support You

Let Cisema help turn your plans into reality.

Request Proposal